TAF only superior to TDF when used with a boosting agent
Non-consensual sex is a recurrent problem in the chemsex environment
REALITY study shows which HIV-positive people with very low CD4 cell counts are at highest risk of dying soon after starting treatment
8-week course of Zepatier cures acute HCV in people with HIV
The chemsex response is reshaping sexual health services and reinventing harm reduction
Loneliness and community are key to chemsex
Integrase inhibitors do not raise risk of IRIS in severely immunocompromised people
South Africa: women may have higher rates of HIV than men because fewer men are on treatment
Switching from abacavir to TAF improves platelet function
